Stock_Titan Posted - 1 month ago

$DXR New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion https://www.stocktitan.net/news/DXR/new-studies-prove-the-clinical-benefits-of-daxor-s-blood-volume-bva-u929s9oh6jgw.html

Stock_Titan Posted - 1 month ago

$DXR DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™) https://www.stocktitan.net/news/DXR/daxor-corporation-to-exhibit-at-the-medaxiom-cardiovascular-1lh4kl6wtlmc.html

Qutiaw Posted - 1 month ago

$ICU Could there be a Daxor ($DXR) relation with ICU?

Stock_Titan Posted - 1 month ago

$DXR Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital https://www.stocktitan.net/news/DXR/daxor-corporation-announces-new-hospital-account-at-leading-chicago-71ylzg628hml.html

Stock_Titan Posted - 1 month ago

$DXR Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24 https://www.stocktitan.net/news/DXR/daxor-corporation-to-exhibit-at-the-american-college-of-cardiology-vjaf3z5e07y2.html

insiderbuyingselling Posted - 03/27/24

$DXR new insider buying: 750 shares. http://insiderbuyingselling.com/?t=DXR

DonCorleone77 Posted - 03/25/24

$DXR Daxor acquires Volumex, Megatope for Iso-Tex Diagnostics Daxor entered into a definitive agreement to acquire exclusive and worldwide rights and intellectual property to manufacture from its existing supplier for Volumex and Megatope from privately-held Iso-Tex Diagnostics, Inc. Daxor has also acquired the exclusive rights to Glofil, a drug that measures glomerular filtration rate, which Iso-Tex has been selling directly to its customer base. Daxor projects the acquisitions to be cash flow positive and accretive to earnings immediately upon transfer of the manufacturing. This is due to the embedded revenue streams of the drugs and significantly higher margins that will be achieved with internalized production. The deals have been structured with seller-provided financing on favorable terms. No payments will come due until manufacturing is fully transitioned to Daxor over the next 6-9 months. The total transaction value will then be paid in monthly installments over two years...

Stock_Titan Posted - 03/25/24

$DXR Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics https://www.stocktitan.net/news/DXR/daxor-corporation-acquires-volumex-r-and-megatope-r-from-its-kx28m80c8d53.html

Stock_Titan Posted - 03/22/24

$DXR Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 https://www.stocktitan.net/news/DXR/daxor-corporation-to-hold-investor-call-discussing-fiscal-year-2023-f4jkn416ziua.html

DutchVH Posted - 2 months ago

$DXR

Stock_Titan Posted - 2 months ago

$DXR Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders https://www.stocktitan.net/news/DXR/daxor-corporation-ceo-and-president-michael-feldschuh-provides-ap54lpwofuvc.html

Stock_Titan Posted - 2 months ago

$DXR Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base https://www.stocktitan.net/news/DXR/daxor-announces-sales-to-three-new-hospitals-furthering-expansion-of-rc0ltirnqosz.html

Stock_Titan Posted - 2 months ago

$DXR Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients https://www.stocktitan.net/news/DXR/multi-center-study-presented-by-duke-at-heart-failure-therapeutics-fb860di34cti.html

Stock_Titan Posted - 02/26/24

$DXR Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference https://www.stocktitan.net/news/DXR/daxor-corporation-to-exhibit-at-the-technology-and-heart-failure-jzjmmlocklbo.html

AlertsAndNews Posted - 3 months ago

Gappers in after hours trading, $CHNR $DXR $NNOX $AREN $SOUN Another crazy day. momentum right now on fire! Enjoy your evening! 🌐

DonCorleone77 Posted - 3 months ago

$DXR Daxor announces two significant customer transactions with BVA-100 Daxor Corporation announces two significant new customer transactions with Daxor's BVA-100 in January, marking a strong start to 2024. New wins include: Four-year lease agreement for the BVA analyzer at an award-winning network of 24 affiliated hospitals in Mississippi, West Tennessee, and East Arkansas with a reach into Kentucky, Missouri, and central Alabama; BVA analyzer purchase at a 200-bed independent hospital in Mississippi. "Our sales and marketing teams have kicked off the new calendar year with great momentum," said Michael Feldschuh, Daxor's CEO and President. "We remain focused on commercialization - broadening our reach with new analyzer purchases, and driving utilization within our current customer base, supported by our ezBVA Lab service."

Stock_Titan Posted - 3 months ago

$DXR Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions https://www.stocktitan.net/news/DXR/daxor-corporation-starts-2024-with-ongoing-growth-in-new-blood-sidge5bpl19c.html

Stock_Titan Posted - 3 months ago

$DXR Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts https://www.stocktitan.net/news/DXR/daxor-corporation-closes-q4-2023-with-growth-in-new-sales-to-6xnlblhgqe0p.html

Stock_Titan Posted - 4 months ago

$DXR DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES https://www.stocktitan.net/news/DXR/daxor-awarded-additional-new-patent-for-smart-blood-volume-guidance-jhm1dl0zxa2g.html

tickeron Posted - 4 months ago

A.I.dvisor made a bullish call on $DXR, netting in a 38.08% gain over 1 month https://srnk.us/go/4962671

StockAutomatePro Posted - 4 months ago

$DXR The chart shows the stock may be headed for a boost. We alerted the BUY signal at $7.599 and we were able to close this one with profit at $10.03 🎲

cctranscripts Posted - 4 months ago

Daxor Corporation Submits Dual 510(K)/Clia-Waiver Application To The Fda For Its Advanced Next- https://www.conferencecalltranscripts.org/summary/?id=12833293 $DXR

Last10K Posted - 4 months ago

$DXR just filed with the SEC a Financial Exhibit https://last10k.com/sec-filings/DXR/0001493152-24-000035.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=DXR

risenhoover Posted - 4 months ago

$DXR / Daxor files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 2, 2024 Daxor Corporation https://fintel.io/doc/sec-daxor-corp-27367-8k-2024-january-02-19724-6018?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

DonCorleone77 Posted - 4 months ago

$DXR Daxor submits dual 510k/CLIA-waiver application to FDA for Daxor BVA Daxor Corporation announces it has submitted its next-generation blood volume analyzer - Daxor BVA - to the U.S. Food and Drug Administration, FDA, via the 510(k)/CLIA-waiver dual submission pathway. Potential clearance is expected during the first half of 2024. The Company's mission is to advance healthcare by enabling optimal fluid management. "Today marks a long-anticipated and momentous milestone in our continued commitment to our customers, patients, and to achieving our vision of optimal blood volume for all," said Michael Feldschuh, Daxor's CEO and President. "Funded under contract by the U.S. Department of Defense, our next-generation analyzer will deliver a level of speed, access, and accuracy to blood volume management that can significantly improve care and outcomes in medicine."

Stock_Titan Posted - 4 months ago

$DXR Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer https://www.stocktitan.net/news/DXR/daxor-corporation-submits-dual-510-k-clia-waiver-application-to-the-7g826oogqk7u.html

StockAutomatePro Posted - 12/29/23

$DXR The chart is predicting a profitable future for the stock. We alerted the BUY signal at $7.53 and we were able to close this one with profit at $9.6 💯

tickeron Posted - 12/29/23

A.I.dvisor made a bullish call on $DXR, netting in a 10.63% gain over 1 month https://srnk.us/go/4954399

dividendinvestorbyeagle Posted - 4 months ago

$DXR close increased > 10% (Daxor Corp.) https://www.dividendinvestor.com/dividend-news/?symbol=dxr http://dlvr.it/T0LCx0

cctranscripts Posted - 5 months ago

Daxor Corporation's Chief Financial Officer just picked up 120 shares https://www.conferencecalltranscripts.org/summary/?id=12770200 $DXR